HER2 Support Group Forums - Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE te

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE te (https://her2support.org/vbulletin/showthread.php?t=64060)

News	11-05-2015 03:03 AM

Janssen doses first patient in daratumumab clinical trial using Halozyme's ENHANZE te

Halozyme Therapeutics, Inc. today announced that Janssen Biotech, Inc. has dosed the first patient in a clinical trial evaluating subcutaneous (SC) delivery of daratumumab with Halozyme's proprietary ENHANZE technology in multiple myeloma.

More...

All times are GMT -7. The time now is 07:38 AM.